Introduction With a staggering growth rate since the onset of COVID-19, telemedicine has emerged as a primary method for HCP-to-patient interaction.[1] According to Allied Market Research, the Telemedicine Market generated $40.2 billion in 2020 and is projected to generate $431.82 billion by 2030 with an estimated 25.9% from 2021 to 2030.[2] While many larger clinics and … [Read more...]
Putting Social Data to Work in Medical Affairs
Introduction The emerging role of big data, machine learning, and artificial intelligence in the healthcare and pharmaceutical industries is indisputable.[1,2] While many larger pharmaceutical companies have teams in pharmacovigilance or marketing that monitor, collect, and draw meaningful conclusions from big data (extremely large datasets), medical affairs and field … [Read more...]
A Decade in Review: Changes in Temporal and Regional Interest in the Medical Science Liaison Role
Following the inception of the medical science liaison (MSL) role by Upjohn Pharmaceuticals in 1967, growing demand for MSLs in pharmaceutical, biotechnology, diagnostic, and medical device companies has persisted.1 One of the core responsibilities of any MSL is to serve as an important public resource of scientific and clinical knowledge for their employers.2 To this end, MSLs … [Read more...]